Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · IEX Real-Time Price · USD
2.460
-0.040 (-1.60%)
Apr 25, 2024, 11:13 AM EDT - Market open
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $170.70 million as of April 25, 2024. Its market cap has decreased by -18.25% in one year.
Market Cap
170.70M
Enterprise Value
102.28M
1-Year Change
-18.25%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since January 15, 2021, Alpha Tau Medical's market cap has decreased from $256.50M to $170.70M, a decrease of -33.45%. That is a compound annual growth rate of -11.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 173.50M | -0.40% |
Apr 23, 2024 | 174.20M | 2.47% |
Apr 22, 2024 | 170.00M | -4.71% |
Apr 19, 2024 | 178.40M | -3.72% |
Apr 18, 2024 | 185.30M | -1.12% |
Apr 17, 2024 | 187.40M | -1.63% |
Apr 16, 2024 | 190.50M | -1.65% |
Apr 15, 2024 | 193.70M | -1.42% |
Apr 12, 2024 | 196.50M | -1.40% |
Apr 11, 2024 | 199.30M | 0.35% |
Apr 10, 2024 | 198.60M | -1.34% |
Apr 9, 2024 | 201.30M | 1.00% |
Apr 8, 2024 | 199.30M | -1.34% |
Apr 5, 2024 | 202.00M | - |
Apr 4, 2024 | 202.00M | - |
Apr 3, 2024 | 202.00M | 0.35% |
Apr 2, 2024 | 201.30M | -0.35% |
Apr 1, 2024 | 202.00M | -1.70% |
Mar 28, 2024 | 205.50M | - |
Mar 27, 2024 | 205.50M | -0.68% |
Mar 26, 2024 | 206.90M | 1.72% |
Mar 25, 2024 | 203.40M | -2.68% |
Mar 22, 2024 | 209.00M | 1.01% |
Mar 21, 2024 | 206.90M | -2.31% |
Mar 20, 2024 | 211.80M | 3.07% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
908 Devices | 182.98M |
Omeros | 179.04M |
Compugen | 177.27M |
Outlook Therapeutics | 176.99M |
Kodiak Sciences | 174.85M |
Candel Therapeutics | 173.44M |
Adicet Bio | 172.56M |
Telomir Pharmaceuticals | 172.33M |